Home
/
Yubo International Biotech Ltd
/
Financials
/
Quarterly
Yubo International Biotech Ltd — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Yubo International Biotech Ltd filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 14, 2025
Q2
2025
Jun 30, 2025
$0
Aug 13, 2025
Q1
2025
Mar 31, 2025
$0
May 14, 2025
Q3
2025
Sep 30, 2024
$0
Nov 14, 2025
Q2
2025
Jun 30, 2024
$0
Aug 13, 2025
Q1
2025
Mar 31, 2024
$3.5K
May 14, 2025
Q3
2024
Sep 30, 2023
$428.5K
Nov 13, 2024
Q2
2024
Jun 30, 2023
$1.4K
Aug 19, 2024
Q1
2024
Mar 31, 2023
$156.6K
May 20, 2024
Q3
2023
Sep 30, 2022
$14.6K
Nov 20, 2023
Q2
2023
Jun 30, 2022
$8.0K
Aug 11, 2023
Q1
2023
Mar 31, 2022
$15.2K
May 15, 2023
Q3
2022
Sep 30, 2021
$98.3K
Nov 16, 2022
Q3
2021
Nov 30, 2020
$0
Jan 19, 2021
Q2
2021
Aug 31, 2020
$0
Oct 20, 2020
Q1
2021
May 31, 2020
$0
Jul 20, 2020
Q3
2021
Nov 30, 2019
$0
Jan 19, 2021
Q2
2021
Aug 31, 2019
$0
Oct 20, 2020
Q1
2021
May 31, 2019
$0
Jul 20, 2020
Q3
2020
Nov 30, 2018
$0
Jan 13, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($310.2K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($230.3K)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($435.6K)
May 14, 2025
Q3
2025
Sep 30, 2024
($621.1K)
Nov 14, 2025
Q3
2024
Jun 30, 2024
($598.3K)
Nov 13, 2024
Q2
2025
Jun 30, 2024
($527.5K)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($377.3K)
May 14, 2025
Q3
2024
Mar 31, 2024
($409.5K)
Nov 13, 2024
Q2
2024
Mar 31, 2024
($409.5K)
Aug 19, 2024
Q3
2024
Sep 30, 2023
$6.3K
Nov 13, 2024
Q3
2024
Jun 30, 2023
($367.3K)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($367.3K)
Aug 19, 2024
Q3
2024
Mar 31, 2023
($316.7K)
Nov 13, 2024
Q2
2024
Mar 31, 2023
($316.7K)
Aug 19, 2024
Q1
2024
Mar 31, 2023
($316.7K)
May 20, 2024
Q3
2023
Sep 30, 2022
($238.1K)
Nov 20, 2023
Q3
2023
Jun 30, 2022
($491.6K)
Nov 20, 2023
Q2
2023
Jun 30, 2022
($491.6K)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($578.9K)
May 15, 2023
Q2
2023
Mar 31, 2022
($578.9K)
Aug 11, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($310.1K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($249.7K)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($467.3K)
May 14, 2025
Q3
2025
Sep 30, 2024
($532.8K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($470.4K)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($409.4K)
May 14, 2025
Q3
2024
Sep 30, 2023
$6.4K
Nov 13, 2024
Q2
2024
Jun 30, 2023
($367.3K)
Aug 19, 2024
Q1
2024
Mar 31, 2023
($316.5K)
May 20, 2024
Q3
2023
Sep 30, 2022
($238.3K)
Nov 20, 2023
Q2
2023
Jun 30, 2022
($491.5K)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($578.9K)
May 15, 2023
Q2
2021
Sep 30, 2021
($346.0K)
Nov 15, 2021
Q3
2022
Sep 30, 2021
($346.0K)
Nov 16, 2022
Q2
2022
Jun 30, 2021
($370.1K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($438.6K)
May 16, 2022
Q3
2021
Nov 30, 2020
($25.5K)
Jan 19, 2021
Q2
2021
Sep 30, 2020
($304.5K)
Nov 15, 2021
Q2
2021
Aug 31, 2020
($21.0K)
Oct 20, 2020
Q2
2021
Jun 30, 2020
($32.1K)
Aug 20, 2021